Sinopharm Group Nine-Month Net Profit Falls to RMB 8.08 Billion

• Sinopharm Group's net profit attributable to equity holders rose year-over-year to RMB 5.31 billion for the nine months ended September 30, 2026.
• Operating revenue fell year-over-year to RMB 427.61 billion.
• Net cash outflows from operating activities narrowed 39% year-over-year to RMB 23.93 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinopharm Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261026-12382427), on October 25, 2026, and is solely responsible for the information contained therein.